Michael Fred Robinson, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1304 Larchmont Ln, Nichols Hills, OK 73116 Phone: 405-848-5258 |
News Archive
Many hospices may be discouraging enrollment for the highest cost treatments, and Medicare's way of paying them may be part of the problem, a new study finds.
ISTA Pharmaceuticals, Inc. has announced positive results from the preliminary analysis of its second and final Bepreve (bepotastine ophthalmic solution) Phase III clinical study.
Cancer Research UK scientists have discovered a missing link in the way cells protect themselves against cancer, according to research published in Genes & Development.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
› Verified 2 days ago